Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Marqeta Inc (MQ) vs Marsh & McLennan Companies, Inc. (MRSH) Price & Performance

Marqeta IncTrade
Marsh & McLennan Companies, Inc.Trade

Price performance (Past 24H)

Key statistics

Marqeta Inc vs Marsh & McLennan Companies, Inc. — how do they compare? Marqeta Inc trades at $17.89 (market cap $1.82B), while Marsh & McLennan Companies, Inc. trades at $175.71 (market cap $84.31B). The key difference: Marsh & McLennan Companies, Inc. is far larger — about 46.3× Marqeta Inc's market cap, and Marsh & McLennan Companies, Inc. pays a 2.24% dividend while Marqeta Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Marqeta Inc for 44 Days and Marsh & McLennan Companies, Inc. for 109 Days on average.

MQMRSH
Market Cap
$1.82B$84.31B
Volume
1,126,4663,948,947
Sector
TechnologyFinancials
52-Week High
$20.32$207.02
52-Week Low
$15.04$157.32
Typical Hold Time
44 Days109 Days
Enterprise Value
$1.13B$104.99B
Dividend Yield
—2.24%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Marqeta Inc

Marqeta (MQ) trades at $17.86, up 4.69% with a bullish technical outlook. The company shows improving fundamentals with three consecutive quarterly earnings beats and positive cash flow generation in 2025. Recent partnerships with BVNK for stablecoin cards and Google for kids' wallets highlight strategic growth initiatives. However, valuation remains elevated with a P/E of 193.83 and EV/EBITDA of 54.37 despite modest profitability metrics.

MQ presents a mixed investment case with strong operational momentum but premium valuation. The stock offers growth potential through expanding payment partnerships and product innovation, though faces risks from contract renewals and competitive pressure. Analyst consensus at $11.38 suggests caution despite recent positive earnings revisions and institutional interest in the fintech sector.

Marsh & McLennan Companies, Inc.

MRSH trades at $176.16, up 1.44% today, with a bullish technical signal and consistent earnings beats in recent quarters. The company completed the acquisition of Accel Holdings on October 2, 2026, expanding its advisory footprint. Revenue grew to $27.0B in 2025, with a net income margin of 15.41%, while valuation ratios like P/E of 21.57 and ROE of 25.72% reflect strong profitability. Analysts maintain a consensus price target of $202.71, though sentiment is mixed with a 'Hold' rating from most.

The outlook for MRSH is positive due to earnings momentum and strategic acquisitions, but risks include competitive pressures and potential margin compression. Upside remains if the company meets Q3 2026 EPS expectations of $1.97, supported by solid cash flow trends. Investors should weigh the high P/B ratio of 5.55 against growth prospects in the reinsurance sector.

Returns comparison

Trailing returns across standard periods

About Marqeta Inc

Headquartered in Oakland, California, and founded in 2010, Marqeta provides its clients with a card-issuing platform that offers the infrastructure and tools necessary to offer digital, physical, and tokenized payment options without the need for a traditional bank. The company's open APIs are designed to allow third parties like DoorDash, Klarna, and Block to rapidly develop and deploy innovative card-based products and payment services without the need to develop the underlying technology. The company generates revenue primarily through processing and ATM fees for cards issued on its platform.

Read more on MQ →

About Marsh & McLennan Companies, Inc.

Marsh & McLennan Companies Inc is a professional services firm that provides advice and solutions in the areas of risk, strategy, and human capital. The company operates through two main segments: risk and insurance services and consulting. In risk and insurance services, the firm offers services via Marsh (an insurance broker) and Guy Carpenter (a risk and reinsurance specialist). The consulting division comprises Mercer (a provider of human resource services) and Oliver Wyman (management and economic consultancy).

Read more on MRSH →